Times Online - Guest contributors (Free subscription) | 31/08/2008
A 40-year-old mother of two young children with kidney cancer wants a new drug – it’s her only hope. The emergency room wants another triage nurse to reduce waiting times from four to two hours. And the ophthalmologists want to give two patients a new drug to prevent age-related blindness. Each intervention will cost £30,000. You only have £30,000 left – it’s your call.
Tim Worstall (Free subscription) | 17/08/2008
This article is. Some very confused ideas about the costs of drugs: Kidney cancer drugs could be produced for about a tenth of their current cost, Rawlins said. While developing such medicines from scratch added to these costs, as did some ‘unnecessary’ bureaucracy around clinical trials which should be scrapped, he said that was not the [...]
http://www.CelebrityVideoTube.com (Free subscription) | 16/08/2008
Breitbart Brazilian singer and songwriter, has died today at the age of 94 at his Rio de Janeiro home. His death was caused by kidney cancer and multiple organ failures. Caymmi wrote over one hundred songs in … Read the full article here
Medical,Health News and Articles (Free subscription) | 09/08/2008
A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen [...]
PharmaGossip (Free subscription) | 08/08/2008
Pressure on pharmaceutical companies to lower the price of expensive cancer drugs was ramped up on Thursday after NICE, the UK's National Institute for Clinical Excellence, rejected four drugs that treat advanced kidney cancer. In an appraisal consultation document, NICE recommended against making Pfizer's Sutent, Roche's Avastin, Bayer's and Onyx's Nexavar and Wyeth's Torisel available on the NHS...
Scotsman.com (Free subscription) | 08/08/2008
It is ridiculous that in one of the world's wealthiest countries, kidney cancer patients seem likely, because of cost, to be denied effective drugs which would double thei
The Independent (Free subscription) | 08/08/2008
Campaigners expressed outrage yesterday at a decision to deny four drug treatments to NHS patients with advanced kidney cancer.
Paul Flynn - Read My Day (Free subscription) | 07/08/2008
Greed rules Only someone subhuman could fail to be moved by the plight of the kidney cancer patients who are denied drugs that could add months to their lives. Hard choices are unavoidable. The £30,000 per patient used could save...
The Guardian (Free subscription) | 07/08/2008
Peter Johnson: Today's judgment raises questions about how Nice evaluates drugs, particularly for cancers that affect a relatively small number of people
The anger of a Quiet Man (Free subscription) | 07/08/2008
Drugs that can keep cancer sufferers alive (bevacizumab, sorafenib, sunitinib and temsirolimus) are to be denied to patients because they do not represent value for money. link > Patients with advanced kidney cancer will be denied four treatments on the NHS under proposals from the government's drugs advisory body. The drugs - bevacizumab, sorafenib, sunitinib and temsirolimus - do not offer value...
Ph articles (Free subscription) | 07/08/2008
A tumult has broken out over the funding of four drugs for advanced kidney cancer after the drugs advisory body NICE said they should not be use on the NHS. Andrew Crabb, from Abingdon in Oxfordshire, got the news on the first anniversary of his diagnosis with the disease - but says he will do everything he can to carry on receiving his drug. The 49-year-old former bricklayer, and his spouse Diane,...
Moreton and Saughall Massie Matters (Free subscription) | 07/08/2008
Ok, so the headline may be emotive, but for many, many people that is the possible outcome of the recent decision of the National Institute for Health and Clinical Excellence (NICE), in saying new drugs that can extend life for those people who have advanced kidney cancer are simply too expensive to provide on the [...]
Reuters UK (Free subscription) | 07/08/2008
LONDON (Reuters) - Kidney cancer patients should not be treated with four expensive new medicines on the National Health Service, the country's health cost-effectiveness watchdog said on Thursday.
BBC News (Free subscription) | 07/08/2008
A cancer specialist criticises a recommendation that four drug treatments for kidney cancer remain unavailable on the NHS.
Sky News (Free subscription) | 07/08/2008
Patients with advanced kidney cancer are to be denied four treatments on the NHS.
